Analysts at HC Wainwright cut their FY2024 earnings estimates for shares of Mawson Infrastructure Group in a note issued to investors on Tuesday, November 26th. HC Wainwright analyst K. Dede now ...

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of SoundHound AI ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Equities researchers at HC Wainwright reduced their FY2024 EPS estimates for Oruka Therapeutics in a research report issued ...

Fintel reports that on November 26, 2024, HC Wainwright & Co. downgraded their outlook for Poseida Therapeutics ...

Fintel reports that on November 25, 2024, HC Wainwright & Co. downgraded their outlook for Mainz Biomed N.V. (NasdaqCM:MYNZ) ...

We recently published a list of 10 Best Silver Mining Stocks to Buy Right Now. In this article, we are going to take a look at where MAG Silver Corp.

Analysts at HC Wainwright upped their price target on the shares of MAG Silver Corp. (NYSE:MAG) from $17.00 to $18.00, giving ...

H.C. Wainwright analyst Kevin Dede reiterated a Hold rating on LM Funding America (LMFA – Research Report) today. The company’s shares closed yesterday at $2.65. According to TipRanks ...

H.C. Wainwright raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $73 from $61 and keeps a Buy rating on the shares. The firm says Tarsus continues to beat estimates and that it ...

HC, which downgraded Ardelyx to Neutral from ... uncertainty around Medicare patient access for XPHOZAH,” noted H.C. Wainwright analyst Ed Arce. Citi also reduced its price target for the ...